Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis

[1]  S. Itzkowitz,et al.  Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management. , 2021, Gastroenterology.

[2]  Xiaochen Bo,et al.  clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.

[3]  V. Abadie,et al.  B lymphocytes contribute to celiac disease pathogenesis. , 2021, Gastroenterology.

[4]  Timothy L. Bailey,et al.  STREME: Accurate and versatile sequence motif discovery , 2020, bioRxiv.

[5]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[6]  M. Clatworthy,et al.  Distinct microbial and immune niches of the human colon , 2019, bioRxiv.

[7]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[8]  O. Pybus,et al.  Repertoire-wide phylogenetic models of B cell molecular evolution reveal evolutionary signatures of aging and vaccination , 2019, Proceedings of the National Academy of Sciences.

[9]  M. Hattori,et al.  Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis , 2019, Nature Microbiology.

[10]  Rola Dali,et al.  GenPipes: an open-source framework for distributed and scalable genomic analyses , 2018, bioRxiv.

[11]  B. Pariente,et al.  Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis. , 2018, European journal of gastroenterology & hepatology.

[12]  L. Joosten,et al.  Insights into the role of IL-32 in cancer. , 2018, Seminars in immunology.

[13]  N. Harpaz,et al.  High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[15]  Drew M. Pardoll,et al.  Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria , 2018, Science.

[16]  Stephen R. Quake,et al.  Signatures of selection in the human antibody repertoire: Selective sweeps, competing subclones, and neutral drift , 2017, Proceedings of the National Academy of Sciences.

[17]  T. Karlsen,et al.  HLA haplotypes in primary sclerosing cholangitis patients of admixed and non‐European ancestry , 2017, HLA.

[18]  T. Karlsen,et al.  Genetics of primary sclerosing cholangitis and pathophysiological implications , 2017, Nature Reviews Gastroenterology &Hepatology.

[19]  Jeff E. Mold,et al.  Antibody-secreting plasma cells persist for decades in human intestine , 2017, The Journal of experimental medicine.

[20]  Mariza de Andrade,et al.  Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease , 2016, Nature Genetics.

[21]  Gerton Lunter,et al.  A Phylogenetic Codon Substitution Model for Antibody Lineages , 2016, Genetics.

[22]  Davis J. McCarthy,et al.  A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor , 2016, F1000Research.

[23]  S. Mazmanian,et al.  Gut biogeography of the bacterial microbiota , 2015, Nature Reviews Microbiology.

[24]  Jeffrey S. Morris,et al.  The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.

[25]  Laurent Beaugerie,et al.  Cancers complicating inflammatory bowel disease. , 2015, The New England journal of medicine.

[26]  Chunxiao Zhou,et al.  Granzyme M expressed by tumor cells promotes chemoresistance and EMT in vitro and metastasis in vivo associated with STAT3 activation , 2015, Oncotarget.

[27]  A. Regev,et al.  Spatial reconstruction of single-cell gene expression , 2015, Nature Biotechnology.

[28]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[29]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[30]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[31]  D. Bentrem,et al.  β-Catenin Promotes Colitis and Colon Cancer Through Imprinting of Proinflammatory Properties in T Cells , 2014, Science Translational Medicine.

[32]  A. Bitton,et al.  The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients. , 2014, Journal of Crohn's & colitis.

[33]  P. Calabresi,et al.  Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells. , 2013, Cellular immunology.

[34]  M. V. van Oijen,et al.  Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease: An Updated Meta-analysis of Population-based Cohort Studies , 2013, Inflammatory bowel diseases.

[35]  Emma M. B. Weeding,et al.  Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis ‐ a pilot study , 2013, Alimentary pharmacology & therapeutics.

[36]  A. Regev,et al.  Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.

[37]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[38]  Véronique Giudicelli,et al.  IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences. , 2011, Cold Spring Harbor protocols.

[39]  T. Karlsen,et al.  Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: Unique clinical and human leukocyte antigen associations , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[40]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[41]  L. Sollid,et al.  Tissue-mediated control of immunopathology in coeliac disease , 2009, Nature Reviews Immunology.

[42]  R. Odze,et al.  Pathologic Features of Ulcerative Colitis in Patients With Primary Sclerosing Cholangitis: A Case-control Study , 2009, The American journal of surgical pathology.

[43]  K. Cox,et al.  Long-term Treatment of Primary Sclerosing Cholangitis in Children With Oral Vancomycin: An Immunomodulating Antibiotic , 2008, Journal of pediatric gastroenterology and nutrition.

[44]  Marie-Paule Lefranc,et al.  IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis , 2008, Nucleic Acids Res..

[45]  D. Hommes,et al.  More right‐sided IBD‐associated colorectal cancer in patients with primary sclerosing cholangitis , 2008, Inflammatory bowel diseases.

[46]  S. Itzkowitz.  Molecular biology of dysplasia and cancer in inflammatory bowel disease. , 2006, Gastroenterology clinics of North America.

[47]  H. Zou,et al.  Regularization and variable selection via the elastic net , 2005 .

[48]  A. Zinsmeister,et al.  PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis , 2004, Gut.

[49]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[50]  Alastair Forbes,et al.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. , 2004, Gastroenterology.

[51]  P. Brandtzaeg,et al.  Immunoglobulin A cell distribution in the human small intestine: phenotypic and functional characteristics , 2000, Immunology.

[52]  C. Benz,et al.  [Primary sclerosing cholangitis]. , 2000, Der Internist.

[53]  K. Shetty,et al.  The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis , 1999, American Journal of Gastroenterology.

[54]  L. Eriksson,et al.  Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential , 1995, Hepatology.

[55]  E. Schrumpf,et al.  Relationship of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis , 1991, Seminars in liver disease.

[56]  E. Campo,et al.  Regional distribution of glycoconjugates in normal, transitional and neoplastic human colonic mucosa , 1989, Virchows Archiv A.

[57]  M. Gerich,et al.  Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease , 2017 .

[58]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[59]  M. Vatn,et al.  Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time , 1999, American Journal of Gastroenterology.